Although the company has said that it did not make this marketing decision because of lawsuits or regulations, the fact remains that there is a recent marked increase of scrutiny of metal-on-metal hips.
(PRWEB) May 17, 2013
Johnson & Johnson subsidiary DePuy Orthopaedics announced on May 16 that it will stop sales of metal-on-metal hip replacements. This comes after the company saw the market for the products drop significantly* amid lawsuits and calls for increased regulation,** and after the 2010 recall of the DePuy ASR hip implant. The Rottenstein Law Group LLP, a metal-on-metal hip implant law firm, applauds the decision to remove these products from the market and notes that it maintains a comprehensive website at http://www.hipreplacementlawsuitcenter.com with information on the metal-on-metal hip products from a variety of companies facing increased scrutiny.
Johnson & Johnson said its decision to stop selling the metal liners in the Ultamet Metal-on-Metal Articulation and Complete Ceramic-on-Metal Acetabular Hip System was because of decreased demand and not because of the safety concerns cited by the FDA regarding metal-on-metal hips or the more than 10,000 lawsuits pending against DePuy over the ASR hip implant system (In re: DePuy Orthopaedics Inc., ASR Hip Implant Products Liability Litigation, MDL-2197 (U.S. District Court for the Northern District of Ohio)), according to a May 16 Bloomberg report. The company will continue to sell its DePuy Pinnacle system, though.
“Although the company has said that it did not make this marketing decision because of lawsuits or regulations, the fact remains that there is a recent marked increase of scrutiny of metal-on-metal hips,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.
For those who believe their metal-on-metal hip implant has injured them, the Rottenstein Law Group LLP offers an in-depth look at hip replacement settlements for metal-on-metal hip implants manufactured by DePuy, Stryker, Smith & Nephew, Biomet and Wright Medical. Common alleged side effects the firm hears about include metallosis (metal poisoning) and the need for revision surgery. The first trial in the country in Los Angeles resulted in the plaintiff winning an $8.3 million damages award (Kransky v. DePuy; BC456086, Los Angeles Superior Court).
For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP’s Injury Lawyer Newswire at injurylawyernewswire.com. Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.
About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com